Atai Beckley N.V. (ATAI) — 8-K Filings

8-K Filings (35)

• Atai Beckley N.V. Files 8-K — Dec 5, 2025 Risk: low
  Atai Beckley N.V. filed an 8-K on December 5, 2025, reporting other events and financial statements. The company, previously known as ATAI Life Sciences N.V., i
• 8-K Filing — Nov 12, 2025
• ATAI Life Sciences Files 8-K on Asset Deal & Equity Sales — Nov 5, 2025 Risk: medium
  On November 5, 2025, ATAI Life Sciences N.V. filed an 8-K report detailing the completion of an acquisition or disposition of assets. The filing also covers unr
• 8-K Filing — Nov 4, 2025
• ATAI Life Sciences Files 8-K for Material Agreement — Oct 27, 2025 Risk: medium
  On October 23, 2025, ATAI Life Sciences N.V. entered into a material definitive agreement. The company also reported other events and filed financial statements
• ATAI Life Sciences Files 8-K Report — Oct 21, 2025 Risk: low
  On October 20, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and other events, along with financial
• ATAI Life Sciences Files 8-K for Material Agreement — Oct 20, 2025 Risk: medium
  On October 16, 2025, ATAI Life Sciences N.V. entered into a material definitive agreement. The company also reported its results of operations and financial con
• ATAI Life Sciences Files 8-K Report — Oct 16, 2025 Risk: low
  On October 16, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Other Events, along with Financial
• ATAI Life Sciences Files 8-K Report — Oct 10, 2025 Risk: low
  On October 10, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicati
• ATAI Life Sciences Files 8-K Report — Sep 29, 2025 Risk: low
  On September 29, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No spe
• ATAI Life Sciences Files 8-K Report — Sep 23, 2025 Risk: low
  On September 23, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing indicates that the company is providing information related to Regulation FD disc
• ATAI Life Sciences Files 8-K for Financial Updates — Aug 14, 2025 Risk: low
  On August 14, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns the company's financial statements and exhibits, indicating a reg
• ATAI Life Sciences Files 8-K with Key Agreements and Equity Sales — Jul 1, 2025 Risk: medium
  On July 1, 2025, ATAI Life Sciences N.V. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, unregist
• ATAI Life Sciences Files 8-K on Material Agreement — Jun 2, 2025 Risk: medium
  On June 2, 2025, ATAI Life Sciences N.V. filed an 8-K report detailing a material definitive agreement. The filing also disclosed unregistered sales of equity s
• ATAI Life Sciences N.V. Files 8-K on Security Holder Vote — May 21, 2025 Risk: low
  On May 15, 2025, ATAI Life Sciences N.V. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not specify the ex
• ATAI Life Sciences Files 8-K on Financials — May 14, 2025 Risk: low
  On May 14, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
• ATAI Life Sciences Terminates Material Agreement — May 8, 2025 Risk: medium
  On May 2, 2025, ATAI Life Sciences N.V. reported the termination of a material definitive agreement and triggering events that accelerate or increase financial
• ATAI Life Sciences Appoints New Director, Adjusts CMO Compensation — Apr 30, 2025 Risk: medium
  On April 24, 2025, ATAI Life Sciences N.V. reported the departure of Director Srinivas Rao and the appointment of Dr. Josef von Ferber as a new director. The co
• ATAI Life Sciences Files 8-K Report — Mar 20, 2025 Risk: low
  On March 20, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing indicates that the company is incorporated in The Netherlands and its principal execu
• ATAI Life Sciences Files 8-K on Financials — Mar 17, 2025 Risk: low
  On March 17, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as we
• ATAI Life Sciences Files 8-K: Material Agreement & Disclosures — Feb 13, 2025 Risk: medium
  On February 12, 2025, ATAI Life Sciences N.V. entered into a material definitive agreement. The company also issued a Regulation FD disclosure and reported othe
• ATAI Life Sciences Reports Leadership Changes — Jan 24, 2025 Risk: medium
  On January 19, 2025, ATAI Life Sciences N.V. reported changes in its board of directors and executive officers. The filing details the departure of certain dire
• ATAI Life Sciences Announces Director Changes and Officer Compensation Updates — Jan 10, 2025 Risk: medium
  On January 7, 2025, ATAI Life Sciences N.V. reported a departure of a director, Dr. Srinivas Rao, and the election of a new director, Dr. Jonathan Roth. The com
• ATAI Life Sciences Files 8-K on Financials — Nov 13, 2024 Risk: low
  On November 13, 2024, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, al
• ATAI Life Sciences Files 8-K Report — Oct 4, 2024 Risk: medium
  On October 2, 2024, ATAI Life Sciences N.V. filed an 8-K report to disclose other events. The filing does not contain specific details about the nature of these
• ATAI Life Sciences Files 8-K on Material Agreement — Aug 14, 2024 Risk: medium
  On August 14, 2024, ATAI Life Sciences N.V. filed an 8-K report detailing a material definitive agreement. The filing also indicates the creation of a direct fi
• ATAI Life Sciences N.V. Files 8-K Report — Aug 13, 2024 Risk: low
  On August 13, 2024, ATAI Life Sciences N.V. filed an 8-K report. The filing indicates the company's principal executive offices are located at Wallstraße 16, 10
• ATAI Life Sciences Files 8-K with Financials — Jun 5, 2024 Risk: low
  On June 5, 2024, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events
• ATAI Life Sciences Announces Director Changes and Compensation Updates — May 23, 2024 Risk: medium
  On May 17, 2024, ATAI Life Sciences N.V. filed an 8-K report detailing several key events. These include the departure of Director Dr. Srinivas Rao, the electio
• ATAI Life Sciences Reports Q1 Loss, Appoints New CSO — May 15, 2024 Risk: medium
  On May 14, 2024, ATAI Life Sciences N.V. reported its first quarter 2024 financial results, showing a net loss of $54.6 million. The company also announced the
• ATAI Life Sciences Files 8-K on Financials — Mar 28, 2024 Risk: low
  On March 28, 2024, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as we
• ATAI Life Sciences 8-K Signals Officer/Director Changes, Comp. Arrangements — Feb 6, 2024
  ATAI Life Sciences N.V. filed an 8-K on February 6, 2024, reporting an event that occurred on February 1, 2024. This filing indicates changes related to the 'De
• ATAI Life Sciences Reports Material Agreement & Asset Transaction — Jan 23, 2024
  ATAI Life Sciences N.V. filed an 8-K on January 23, 2024, reporting an event from January 18, 2024, related to an entry into a material definitive agreement and
• ATAI Life Sciences Files 8-K, Confirms Nasdaq Listing — Jan 9, 2024
  ATAI Life Sciences N.V. filed an 8-K on January 9, 2024, reporting an event that occurred on January 7, 2024. This filing is a routine update to their registrat
• ATAI Life Sciences Reports Material Agreement & Asset Acquisition/Disposition — Jan 4, 2024
  ATAI Life Sciences N.V. filed an 8-K on January 3, 2024, to report the entry into a material definitive agreement and the completion of an acquisition or dispos

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX